THU655 Methimazole Desensitization As An Effective Alternative To Ablation Therapy In Patients With Graves’ Disease Experiencing Thionamide-induced Type IV Hypersensitivity Reactions

Disclosure: J. Arguinchona: None. A. Mahajan: None. A. Gonzalez-Estrada: None. E. De Filippis: None. Introduction: Patients with newly diagnosed Graves’ disease often choose treatment with methimazole (MMI) over traditional ablation therapies. However, MMI can result in adverse reactions including s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arguinchona, Joseph, Mahajan, Avanika, Gonzalez-Estrada, Alexei, De Filippis, Eleanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554422/
http://dx.doi.org/10.1210/jendso/bvad114.1778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554422/
http://dx.doi.org/10.1210/jendso/bvad114.1778

Ejemplares similares